Journal Highlight : Molecular Therapeutics
The journal welcomes scholarly contributions related to the discovery, development, and application of molecular-level therapeutic strategies for the prevention, diagnosis, and treatment of diseases. This section focuses on research that advances understanding of disease mechanisms at the molecular level and translates these insights into targeted, effective, and personalized treatment approaches.
The journal encourages submissions in areas including Targeted Molecular Therapies, Drug Discovery and Development, Small Molecule Therapeutics, Biologics and Biosimilars, Monoclonal Antibody Therapies, Gene and Cell Therapies, RNA-Based Therapeutics, Immunotherapies, and Precision Medicine Approaches. Research related to Pharmacogenomics, Molecular Pharmacology, Signal Transduction Targeting, Cancer Therapeutics, Antiviral and Antimicrobial Agents, and Neurotherapeutics is also welcomed.
Submissions focusing on Drug Mechanism of Action, Therapeutic Resistance Mechanisms, Drug Delivery Systems and Nanomedicine, Biomarker-Guided Therapy, Translational Drug Development, Preclinical and Clinical Therapeutic Evaluation, Combination Therapy Strategies, and AI and Computational Drug Design are encouraged. The journal also welcomes studies investigating molecular targets, therapeutic efficacy, safety profiles, and innovation in next-generation therapeutic platforms across diverse disease areas.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental Studies, Preclinical and Clinical Trials, Translational Research Articles, Case Reports, and Methodology and Technology Reports that contribute to advancements in molecular therapeutics.
Through this focus area, the journal aims to support research that advances molecular-based treatment strategies, accelerates drug discovery and development, improves therapeutic precision and patient outcomes, and contributes to innovation in modern biomedical and clinical medicine.
